Grössmann-Waniek, N. and Wild, C. and Malíková, E. and Wolf, S. and Fabian, D. and Sehic, O. and Zechmeister-Koss, I. (2025): Exagamglogene autotemcel (Exa-cel, Casgevy®) for the treatment of beta-thalassaemia and severe sickle cell disease. AIHTA Appraisal Board Assessment Nr.: 001.

AIHTA, HTA Austria (2025): Annual Report 2024.

Mayer-Ferbas, J. and Jeindl, R. (2025): Reimbursement models and pricing of digital health technologies and telemonitoring applications – Rapid scoping review. Rapid Review Nr.: 016.